Search | IOVS | ARVO Journals

Showing 1 – 20 of 20

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Glaucoma February 2013

Series Length Used during Trend Analysis Affects Sensitivity to Changes in Progression Rate in the Ocular Hypertension Treatment Study

PDF

Stuart K. Gardiner; Shaban Demirel; Carlos Gustavo De Moraes; Jeffrey M. Liebmann; George A. Cioffi; Robert Ritch; Mae O. Gordon; Michael A. Kass; for the Ocular Hypertension Treatment Study Group
TAGS: eye, ocular hypertension, trend, universities, ophthalmology
Invest. Ophthalmol. Vis. Sci.. 2013; 54(2):1252-1259. https://doi.org/10.1167/iovs.12-10218

Clinical Trials April 2012

Effect of Treatment on the Rate of Visual Field Change in the Ocular Hypertension Treatment Study Observation Group

PDF

Carlos Gustavo De Moraes; Shaban Demirel; Stuart K. Gardiner; Jeffrey M. Liebmann; George A. Cioffi; Robert Ritch; Mae O. Gordon; Michael A. Kass; For the Ocular Hypertension Treatment Study Group
TAGS: eye, ocular hypertension, open-angle glaucoma, velocity, visual fields
Invest. Ophthalmol. Vis. Sci.. 2012; 53(4):1704-1709. https://doi.org/10.1167/iovs.11-8186

ARVO Annual Meeting Abstract April 2011

Does Greater Long-term Intraocular Pressure (IOP) Variability Increase Probability Of Developing Primary Open Angle Glaucoma (POAG) in the Ocular Hypertension Treatement Study (OHTS)?

Mae O. Gordon; Julia A. Beiser; J. Phillip Miller; Michael Kass; Feng Gao; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3442.

ARVO Annual Meeting Abstract April 2010

Does Adjusting IOP for Central Corneal Thickness Improve Accuracy of the Prediction Model for the Development of POAG?

J. D. Brandt; M. O. Gordon; M. A. Kass; J. A. Beiser; F. Gao; Ocular Hypertension Treatment Study Group; European Glaucoma Prevention Study Group

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2708.

ARVO Annual Meeting Abstract April 2009

Quantitating the Impact of Clinical and Basic Science Research

M. E. Gordon; C. Sarli; E. K. Dubinsky; E. Long; C. LaRue; M. A. Kass; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2469.

ARVO Annual Meeting Abstract May 2008

The 20-Year Incidence of Primary Open Angle Glaucoma Among People With Ocular Hypertension---A Decision Analytic Approach

S. M. Kymes; M. A. Kass; J. P. Miller; M. O. Gordon; the Ocular Hypertension Treatment Study group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5055.

ARVO Annual Meeting Abstract May 2008

Retinal Vein Occlusions (RVO) in the Ocular Hypertension Treatment Study (OHTS)

E. M. Barnett; A. Fantin; B. S. Wilson; M. A. Kass; M. O. Gordon; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5463.

ARVO Annual Meeting Abstract May 2008

Intraocular Pressure Variability in Observation Participants in the Ocular Hypertension Treatment Study (OHTS)

A. M. Bhorade; B. S. Wilson; P. Palmberg; E. Miller; R. Weinreb; M. A. Kass; M. O. Gordon; The Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2048.

ARVO Annual Meeting Abstract May 2008

Application of Brusini’s Glaucoma Staging System 2 (GSS 2) to Glaucomatous Visual Fields in the Ocular Hypertension Treatment Study (OHTS)

J. L. Keltner; C. A. Johnson; K. E. Cello; P. Brusini; M. A. Kass; M. O. Gordon; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1102.

ARVO Annual Meeting Abstract May 2007

A Comparison of Full Threshold and Swedish Interactive Threshold Algorithms (SITA) Testing Procedures in the Ocular Hypertension Treatment Study (OHTS)

S. E. Bandermann; J. L. Keltner; C. A. Johnson; K. E. Cello; M. A. Kass; M. O. Gordon; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1643.

ARVO Annual Meeting Abstract May 2007

Longitudinal and Cross-Sectional Analyses of Visual Field Progression in the Ocular Hypertension Treatment Study (OHTS)

P. H. Artes; B. C. Chauhan; C. A. Johnson; J. L. Keltner; K. E. Cello; M. A. Kass; M. O. Gordon; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):4447.

ARVO Annual Meeting Abstract May 2007

The Predictive Accuracy of the One-Eyed Trial in the Ocular Hypertension Treatment Study (OHTS)

A. M. Bhorade; B. S. Wilson; P. Palmberg; E. Miller; R. T. Chang; M. A. Kass; M. O. Gordon; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):5555.

Glaucoma September 2006

Asymmetries and Visual Field Summaries as Predictors of Glaucoma in the Ocular Hypertension Treatment Study

PDF

Richard A. Levine; Shaban Demirel; Juanjuan Fan; John L. Keltner; Chris A. Johnson; Michael A. Kass; the Ocular Hypertension Treatment Study Group
TAGS: eye, glaucoma, ocular hypertension, open-angle glaucoma, visual fields, intraocular pressure
Invest. Ophthalmol. Vis. Sci.. 2006; 47(9):3896-3903. https://doi.org/10.1167/iovs.05-0469

ARVO Annual Meeting Abstract May 2006

Visual Field Quality Control in the Ocular Hypertension Treatment Study (OHTS) and the Optic Neuritis Treatment Trial (ONTT)

J.L. Keltner; C.A. Johnson; K.E. Cello; J. Fan; R.A. Levine; S.E. Bandermann; M.A. Kass; M.O. Gordon; R.W. Beck; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3394.

ARVO Annual Meeting Abstract May 2005

Test–Retest Reproducibility of Determining Optic Disc Deterioration in the Ocular Hypertension Treatment Study (OHTS):

R. Parrish; J.C. Schiffman; W.J. Feuer; D.R. Anderson; D.L. Budenz; M.C. Wells–Albornoz; M.A. Kass; M.O. Gordon; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3630.

ARVO Annual Meeting Abstract May 2005

Visual Field Quality Control in the Ocular Hypertension Treatment Study (OHTS): and in the 10–Year Optic Neuritis Treatment Trial (ONTT) Follow–Up Study

J.L. Keltner; C.A. Johnson; K.E. Cello; J. Fan; S.E. Bandermann; M.A. Kass; M.O. Gordon; R.W. Beck; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3738.

ARVO Annual Meeting Abstract May 2005

Comparison of IOP Response to Topical Beta–Adrenergic Antagonists and Prostaglandin Analogues in African Americans and Whites: The Ocular Hypertension Treatment Study (OHTS)

S.L. Mansberger; B.A. Hughes; M.O. Gordon; S.L. Spaner; J.A. Beiser; G.A. Cioffi; M.A. Kass; Ocular Hypertension Treatment Study (OHTS) Group

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):2449.

ARVO Annual Meeting Abstract May 2004

Detection and predictive value of optic disc hemorrhages in the Ocular Hypertensive Treatment Study

D.L. Budenz; J.A. Beiser; J.R. Piltz; R.K. Parrish; D.R. Anderson; M.O. Gordon; M.A. Kass; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):940.

ARVO Annual Meeting Abstract May 2004

Types of Visual Field Abnormalities that Subsequently Become Visual Field Primary Open–Angle Glaucoma in the Ocular Hypertension Treatment Study (OHTS)

J.L. Keltner; C.A. Johnson; J. Fan; K.E. Cello; M.A. Kass; M.O. Gordon; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2134.

ARVO Annual Meeting Abstract May 2003

Classification of Glaucomatous Visual Field Abnormalities In the Ocular Hypertension Treatment Study (OHTS)

J.L. Keltner; C.A. Johnson; J. Fan; K.E. Cello; M.O. Gordon; M.A. Kass; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):75.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Series Length Used during Trend Analysis Affects Sensitivity to Changes in Progression Rate in the Ocular Hypertension Treatment Study

Effect of Treatment on the Rate of Visual Field Change in the Ocular Hypertension Treatment Study Observation Group

Does Greater Long-term Intraocular Pressure (IOP) Variability Increase Probability Of Developing Primary Open Angle Glaucoma (POAG) in the Ocular Hypertension Treatement Study (OHTS)?

Does Adjusting IOP for Central Corneal Thickness Improve Accuracy of the Prediction Model for the Development of POAG?

Quantitating the Impact of Clinical and Basic Science Research

The 20-Year Incidence of Primary Open Angle Glaucoma Among People With Ocular Hypertension---A Decision Analytic Approach

Retinal Vein Occlusions (RVO) in the Ocular Hypertension Treatment Study (OHTS)

Intraocular Pressure Variability in Observation Participants in the Ocular Hypertension Treatment Study (OHTS)

Application of Brusini’s Glaucoma Staging System 2 (GSS 2) to Glaucomatous Visual Fields in the Ocular Hypertension Treatment Study (OHTS)

A Comparison of Full Threshold and Swedish Interactive Threshold Algorithms (SITA) Testing Procedures in the Ocular Hypertension Treatment Study (OHTS)

Longitudinal and Cross-Sectional Analyses of Visual Field Progression in the Ocular Hypertension Treatment Study (OHTS)

The Predictive Accuracy of the One-Eyed Trial in the Ocular Hypertension Treatment Study (OHTS)

Asymmetries and Visual Field Summaries as Predictors of Glaucoma in the Ocular Hypertension Treatment Study

Visual Field Quality Control in the Ocular Hypertension Treatment Study (OHTS) and the Optic Neuritis Treatment Trial (ONTT)

Test–Retest Reproducibility of Determining Optic Disc Deterioration in the Ocular Hypertension Treatment Study (OHTS):

Visual Field Quality Control in the Ocular Hypertension Treatment Study (OHTS): and in the 10–Year Optic Neuritis Treatment Trial (ONTT) Follow–Up Study

Comparison of IOP Response to Topical Beta–Adrenergic Antagonists and Prostaglandin Analogues in African Americans and Whites: The Ocular Hypertension Treatment Study (OHTS)

Detection and predictive value of optic disc hemorrhages in the Ocular Hypertensive Treatment Study

Types of Visual Field Abnormalities that Subsequently Become Visual Field Primary Open–Angle Glaucoma in the Ocular Hypertension Treatment Study (OHTS)

Classification of Glaucomatous Visual Field Abnormalities In the Ocular Hypertension Treatment Study (OHTS)

To View More...

You must be signed into an individual account to use this feature.